Tissue immunoreactive prolactin hormone in breast cancer

A. Castro, P. Buschbaum, Mehrdad Nadji, W. Voigt, J. Ziegels-Weissman, Azorides R Morales

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The prolactin contents of the cytosol extracts of 159 human mammary carcinomas was measured by specific radioimmunoassay. Of these extracts 157 contained measurable prolactin (detection limit, 7.8 ng/g tumor). The levels measured were in most cases greater than would be expected to be due to only serum contamination. The levels of prolactin did not correlate with either estrogen or progesterone receptor content of the tumors, or menopausal status of the patient.

Original languageEnglish
Pages (from-to)159-170
Number of pages12
JournalResearch Communications in Chemical Pathology and Pharmacology
Volume29
Issue number1
StatePublished - Sep 12 1980

Fingerprint

Prolactin
Hormones
Tissue
Breast Neoplasms
Tumors
Progesterone Receptors
Estrogen Receptors
Cytosol
Radioimmunoassay
Limit of Detection
Neoplasms
Contamination
Serum

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Castro, A., Buschbaum, P., Nadji, M., Voigt, W., Ziegels-Weissman, J., & Morales, A. R. (1980). Tissue immunoreactive prolactin hormone in breast cancer. Research Communications in Chemical Pathology and Pharmacology, 29(1), 159-170.

Tissue immunoreactive prolactin hormone in breast cancer. / Castro, A.; Buschbaum, P.; Nadji, Mehrdad; Voigt, W.; Ziegels-Weissman, J.; Morales, Azorides R.

In: Research Communications in Chemical Pathology and Pharmacology, Vol. 29, No. 1, 12.09.1980, p. 159-170.

Research output: Contribution to journalArticle

Castro, A, Buschbaum, P, Nadji, M, Voigt, W, Ziegels-Weissman, J & Morales, AR 1980, 'Tissue immunoreactive prolactin hormone in breast cancer', Research Communications in Chemical Pathology and Pharmacology, vol. 29, no. 1, pp. 159-170.
Castro A, Buschbaum P, Nadji M, Voigt W, Ziegels-Weissman J, Morales AR. Tissue immunoreactive prolactin hormone in breast cancer. Research Communications in Chemical Pathology and Pharmacology. 1980 Sep 12;29(1):159-170.
Castro, A. ; Buschbaum, P. ; Nadji, Mehrdad ; Voigt, W. ; Ziegels-Weissman, J. ; Morales, Azorides R. / Tissue immunoreactive prolactin hormone in breast cancer. In: Research Communications in Chemical Pathology and Pharmacology. 1980 ; Vol. 29, No. 1. pp. 159-170.
@article{36554cae7e614d5fa8b8e1535a54fd02,
title = "Tissue immunoreactive prolactin hormone in breast cancer",
abstract = "The prolactin contents of the cytosol extracts of 159 human mammary carcinomas was measured by specific radioimmunoassay. Of these extracts 157 contained measurable prolactin (detection limit, 7.8 ng/g tumor). The levels measured were in most cases greater than would be expected to be due to only serum contamination. The levels of prolactin did not correlate with either estrogen or progesterone receptor content of the tumors, or menopausal status of the patient.",
author = "A. Castro and P. Buschbaum and Mehrdad Nadji and W. Voigt and J. Ziegels-Weissman and Morales, {Azorides R}",
year = "1980",
month = "9",
day = "12",
language = "English",
volume = "29",
pages = "159--170",
journal = "Research Communications in Molecular Pathology and Pharmacology",
issn = "0034-5164",
publisher = "PJD Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Tissue immunoreactive prolactin hormone in breast cancer

AU - Castro, A.

AU - Buschbaum, P.

AU - Nadji, Mehrdad

AU - Voigt, W.

AU - Ziegels-Weissman, J.

AU - Morales, Azorides R

PY - 1980/9/12

Y1 - 1980/9/12

N2 - The prolactin contents of the cytosol extracts of 159 human mammary carcinomas was measured by specific radioimmunoassay. Of these extracts 157 contained measurable prolactin (detection limit, 7.8 ng/g tumor). The levels measured were in most cases greater than would be expected to be due to only serum contamination. The levels of prolactin did not correlate with either estrogen or progesterone receptor content of the tumors, or menopausal status of the patient.

AB - The prolactin contents of the cytosol extracts of 159 human mammary carcinomas was measured by specific radioimmunoassay. Of these extracts 157 contained measurable prolactin (detection limit, 7.8 ng/g tumor). The levels measured were in most cases greater than would be expected to be due to only serum contamination. The levels of prolactin did not correlate with either estrogen or progesterone receptor content of the tumors, or menopausal status of the patient.

UR - http://www.scopus.com/inward/record.url?scp=0018849292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018849292&partnerID=8YFLogxK

M3 - Article

C2 - 6250206

AN - SCOPUS:0018849292

VL - 29

SP - 159

EP - 170

JO - Research Communications in Molecular Pathology and Pharmacology

JF - Research Communications in Molecular Pathology and Pharmacology

SN - 0034-5164

IS - 1

ER -